Recent News

• 09.17.2025 - Paul Choi
• 09.17.2025 - Paul Choi
• 09.05.2025 - Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
• 09.05.2025 - Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
• 09.02.2025 - Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.02.2025 - Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.06.2025 - Entrada Therapeutics Reports Second Quarter 2025 Financial Results
• 08.06.2025 - Entrada Therapeutics Reports Second Quarter 2025 Financial Results

Recent Filings

• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.06.2025 - EX-99.1 EX-99.1
• 08.06.2025 - 8-K Current report
• 07.11.2025 - 4 Statement of changes in beneficial ownership of securities